Forte Biosciences, Inc. (FBRX)
16.82
-0.18
(-1.06%)
USD |
NASDAQ |
Jun 10, 16:00
16.85
+0.03
(+0.18%)
After-Hours: 07:47
Forte Biosciences 1 Year Total Returns (Daily) : 37.31% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 37.31% |
| June 09, 2026 | 42.26% |
| June 08, 2026 | 38.43% |
| June 05, 2026 | 59.61% |
| June 04, 2026 | 67.32% |
| June 03, 2026 | 78.01% |
| June 02, 2026 | 105.8% |
| June 01, 2026 | 126.4% |
| May 29, 2026 | 127.6% |
| May 28, 2026 | 114.8% |
| May 27, 2026 | 86.21% |
| May 26, 2026 | 158.4% |
| May 22, 2026 | 187.1% |
| May 21, 2026 | 209.4% |
| May 20, 2026 | 166.9% |
| May 19, 2026 | 167.6% |
| May 18, 2026 | 167.1% |
| May 15, 2026 | 195.1% |
| May 14, 2026 | 215.3% |
| May 13, 2026 | 262.6% |
| May 12, 2026 | 286.8% |
| May 11, 2026 | 307.5% |
| May 08, 2026 | 285.6% |
| May 07, 2026 | 322.8% |
| May 06, 2026 | 319.6% |
| Date | Value |
|---|---|
| May 05, 2026 | 309.8% |
| May 04, 2026 | 309.6% |
| May 01, 2026 | 293.6% |
| April 30, 2026 | 265.2% |
| April 29, 2026 | 281.7% |
| April 28, 2026 | 270.6% |
| April 27, 2026 | 299.6% |
| April 24, 2026 | 294.4% |
| April 23, 2026 | 377.0% |
| April 22, 2026 | 335.5% |
| April 21, 2026 | 368.5% |
| April 20, 2026 | 369.1% |
| April 17, 2026 | 362.1% |
| April 16, 2026 | 332.9% |
| April 15, 2026 | 435.6% |
| April 14, 2026 | 480.0% |
| April 13, 2026 | 482.9% |
| April 10, 2026 | 495.8% |
| April 09, 2026 | 494.7% |
| April 08, 2026 | 372.5% |
| April 07, 2026 | 390.1% |
| April 06, 2026 | 349.7% |
| April 02, 2026 | 248.0% |
| April 01, 2026 | 234.6% |
| March 31, 2026 | 233.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| ACADIA Pharmaceuticals, Inc. | -4.28% |
| Alnylam Pharmaceuticals, Inc. | -3.72% |
| Savara, Inc. | 118.5% |
| Vericel Corp. | -18.21% |
| Biogen, Inc. | 43.36% |